MME and mantle cell lymphoma: In contrast, in MCL patients with lower Ki-67 (< 60%), classic morphology, or low-intermediate MIPI, no significant difference in OS was observed between patients with CD10+ versus CD10-negative MCL (p > 0.05 for all).